WallStreetZenWallStreetZen

NASDAQ: MENS
Jyong Biotech Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Jyong Biotech earnings were -$4.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest MENS earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MENS reported annual earnings of -$4.7M, with 54.7% growth.

MENS earnings history

Current Revenue
$0.0
Current Earnings
-$4.7M
Current Profit Margin
0%

MENS Return on Equity

Insufficient data to display

MENS Return on Assets

Current Company
-34.4%
Current Industry
-9.6%

Be the first to know when MENS announces earnings.

MENS Return on Capital Employed

Current Company
15.19%
Current Industry
-3.7%
MENS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MENS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MENS-$1.86M-$4.67MN/A-$0.06
CNTB-$63.72M-$64.61MN/A-$1.15
AGEN$129.13M$64.39MN/A$1.66
BDTX-$42.95M-$43.21MN/A-$0.77
SPRB-$35.92M-$37.19MN/A-$36.60
View Top Biotech Stocks

Jyong Biotech Earnings Reports & History FAQ

What were Jyong Biotech's earnings last quarter?

Jyong Biotech (NASDAQ: MENS) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total MENS earnings for the quarter were N/A. In the same quarter last year, Jyong Biotech's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Jyong Biotech stock.

Is Jyong Biotech profitable or losing money?

As of the last Jyong Biotech earnings report, Jyong Biotech is currently losing money. Jyong Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$4.67 million, a 54.72% increase year over year.

What was MENS's earnings growth in the past year?

As of Jyong Biotech's earnings date in Q2 2026, Jyong Biotech's earnings has grown year over year. MENS earnings in the past year totalled -$4.67 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.